MARK WOYSHVILLE: Open Payments
NPI 1275612848 · MIDDLEBURG HEIGHTS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,129 in 104 payments from 16 companies in 2025. Trend: 2023 $48,185 · 2024 $18,322 · 2025 $30,129
Speaker / faculty: $19,005Consulting: $7,009Food & beverage: $2,292Travel & lodging: $1,043Honoraria: $780
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $14,455 |
| ABBVIE INC. | 17 | $10,354 |
| Eli Lilly and Company | 3 | $2,793 |
| Lundbeck LLC | 2 | $808 |
| Axsome Therapeutics, Inc. | 15 | $489 |
| E.R. Squibb & Sons, L.L.C. | 11 | $292 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $219 |
| Neurocrine BioSciences, Inc. | 11 | $165 |
| Alkermes, Inc. | 7 | $160 |
| Vanda Pharmaceuticals Inc. | 3 | $107 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, COBENFY, INGREZZA, ARISTADA, HETLIOZ.
Industry payments across OH — which companies pay providers there.
